MiGo Tracker Remote Monitoring of Home Exercise After Stroke
MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke
About This Trial
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
MiGo Tracker
Perform home exercise sessions while wearing MiGo Tracker device that logs exercise data.
Conventional home exercise program
Exercise following printed sheets or booklet